Cutler C, Lee SJ, Arai S, et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278-2289.

During the publication process, a footnote stating that authors Bruce R. Blazar and Steven Pavletic contributed equally to the study was inadvertently deleted. Under “Footnotes” on page 2289, the statement “B.R.B. and S.P. contributed equally to this study” should have been included. The publisher apologizes for the error, which has been corrected in the online version of the article.